showdown hoedown choreography

Xzaavier@day3000+

It’s been a while since I uploaded a blog because I WordPress space was filled, and I cannot buy anymore.

Hope to get used to this format to keep posting daily like I used to

Novel AI model explains retinal sex difference

reposted from https://www.vchri.ca/stories/2024/03/20/novel-ai-model-explains-retinal-sex-difference Novel AI model explains retinal sex difference Stories Mar 20, 2024 3 minutes The approach could lead to further biomarker discoveries to assist in disease diagnostics and early treatment interventions. Artificial intelligence (AI) applications are revolutionizing health diagnostics and precision medicine, yet how they identify patterns of disease in layers of data has largely remained a mystery. Research led by Vancouver Coastal Health Research Institute researcher Dr. Ipek Oruç revealed for the first time AI behaviours that differentiated between female and male retinal images, paving the way for other novel biomarkers of disease to aid in precision care. Dr. Ipek Oruc is an associate professor in the Department of Ophthalmology and Visual Sciences; associate member of the School of Biomedical Engineering; investigator with the Data Science Institute; and director of the NOVA Lab at the University of British Columbia. She is also a principal investigator with ICORD. An expert in visual neuroscience and artificial intelligence applications of retinal image analysis, Oruç’s PNAS Nexus study charts a path for other research teams to peek under the hood of AI algorithms to understand how the algorithm was developed in order to improve patient diagnostics and outcomes using medical imaging. “Our research opens the black box of AI, setting the stage for future research to apply this methodology to leverage its potential and identify previously unseen characteristics of various conditions.” Oruç and her team’s proof-of-concept study examined a convolutional neural network (CNN) model trained to classify patient sex in retinal images. CNNs are a type of deep neural network AI that can mimic human cognition in image processing and classification at superhuman speeds, processing thousands of images in a matter of seconds. The technology is already applied to a number of different AI algorithms using medical imaging for the detection and classification of conditions such as cancers and heart disease. The CNN used in Oruç’s study was trained to detect male and female retinal scans taken using a specialized fundus camera, a mainstay tool of optometry and ophthalmology used to capture images of the retina and other eye features. Ophthalmologists and nonexperts better able to detect retinal sex difference The research team developed and applied a novel methodology to discover for the first time retinal features that differentiate between male and female eyes. They tested 14 exploratory research questions that were derived from the behaviours and decisions of the CNN in what investigators termed the “Inspiration” phase of the model. Nine of the hypotheses revealed significant findings, five of which were verified. These biomarkers of sex difference in retinal images included greater retinal vascularization and a darker ring around the optic disk region in male retinas as compared to female retinas. These two images show subtle differences between male and female retinal images. The male image has a darker area around the optic disk, which appears as a bright spot in the images here, as well as more vasculature and nodes. Researchers then shared these distinguishing features with 26 expert ophthalmologists and 31 nonexperts. Prior to receiving this information, both groups’ ability to detect sex difference in retinal images averaged 50 per cent. After receiving training on the distinguishing characteristics between female and male retinal images discovered through Oruç’s novel methodology, both groups were able to identify the sex of the retinal images with approximately 66 per cent accuracy in the post-training block. This significant improvement is still a ways away from a 100 per cent detection rate, which indicates that additional differences have yet to be discovered to enable greater accuracy, Oruç says. "Our findings showcase an opportunity for biomarker discovery through CNN applications, with the added benefit of equipping medical practitioners with new diagnostic options that can be added to their clinical toolkit.” “We are now investigating other biomarkers present in fundus images that can be identified from CNNs, such as whether changes in the eye might signal a risk of stroke or dementia.” Oruç is also currently working on a study to apply this novel methodology to identify biomarkers in women that could lead to improvements in disease detection and treatment.

Gut microbes can boost the motivation to exercise

source https://www.sciencedaily.com/releases/2022/12/221214113857.htm Gut microbes can boost the motivation to exercise Study in mice uncovers gut-to-brain pathway that increases exercise performance Date: December 14, 2022 Source: University of Pennsylvania School of Medicine Summary: Some species of gut-dwelling bacteria activate nerves in the gut to promote the desire to exercise, according to a study in mice. The study reveals the gut-to-brain pathway that explains why some bacteria boost exercise performance. Share: FULL STORY Some species of gut-dwelling bacteria activate nerves in the gut to promote the desire to exercise, according to a study in mice that was led by researchers at the Perelman School of Medicine at the University of Pennsylvania. The study was published today in Nature, and reveals the gut-to-brain pathway that explains why some bacteria boost exercise performance. In the study, the researchers found that differences in running performance within a large group of lab mice were largely attributable to the presence of certain gut bacterial species in the higher-performing animals. The researchers traced this effect to small molecules called metabolites that the bacteria produce -- metabolites that stimulate sensory nerves in the gut to enhance activity in a motivation-controlling brain region during exercise. "If we can confirm the presence of a similar pathway in humans, it could offer an effective way to boost people's levels of exercise to improve public health generally," said study senior author Christoph Thaiss, PhD, an assistant professor of Microbiology at Penn Medicine. Thaiss and colleagues set up the study to search broadly for factors that determine exercise performance. They recorded the genome sequences, gut bacterial species, bloodstream metabolites, and other data for genetically diverse mice. They then measured the amount of daily voluntary wheel running the animals did, as well as their endurance. The researchers analyzed these data using machine learning, seeking attributes of the mice that could best explain the animals' sizeable inter-individual differences in running performance. They were surprised to find that genetics seemed to account for only a small portion of these performance differences -- whereas differences in gut bacterial populations appeared to be substantially more important. In fact, they observed that giving mice broad-spectrum antibiotics to get rid of their gut bacteria reduced the mice's running performance by about half. Ultimately, in a years-long process of scientific detective work involving more than a dozen separate laboratories at Penn and elsewhere, the researchers found that two bacterial species closely tied to better performance, Eubacterium rectale and Coprococcus eutactus, produce metabolites known as fatty acid amides (FAAs). The latter stimulate receptors called CB1 endocannabinoid receptors on gut-embedded sensory nerves, which connect to the brain via the spine. The stimulation of these CB1 receptor-studded nerves causes an increase in levels of the neurotransmitter dopamine during exercise, in a brain region called the ventral striatum. The striatum is a critical node in the brain's reward and motivation network. The researchers concluded that the extra dopamine in this region during exercise boosts performance by reinforcing the desire to exercise. "This gut-to-brain motivation pathway might have evolved to connect nutrient availability and the state of the gut bacterial population to the readiness to engage in prolonged physical activity," said study co-author, J. Nicholas Betley, PhD, an associate professor of Biology at the University of Pennsylvania's School of Arts and Sciences. "This line of research could develop into a whole new branch of exercise physiology." The findings open up many new avenues of scientific investigation. For example, there was evidence from the experiments that the better-performing mice experienced a more intense "runner's high" -- measured in this case by a reduction in pain sensitivity -- hinting that this well-known phenomenon is also at least partly controlled by gut bacteria. The team now plans further studies to confirm the existence of this gut-to-brain pathway in humans. Apart from possibly offering cheap, safe, diet-based ways of getting ordinary people running and optimizing elite athletes' performance, he added, the exploration of this pathway might also yield easier methods for modifying motivation and mood in settings such as addiction and depression. The study was led by Penn Medicine scientist Lenka Dohnalová. Other Penn Medicine authors include: Patrick Lundgren, Jamie Carty, Nitsan Goldstein, Lev Litichevskiy, Hélène Descamps, Karthikeyani Chellappa, Ana Glassman, Susanne Kessler, Jihee Kim, Timothy Cox, Oxana Dmitrieva-Posocco, Andrea Wong, Erik Allman, Soumita Ghosh, Nitika Sharma, Kasturi Sengupta, Mark Sellmyer, Garret FitzGerald, Andrew Patterson, Joseph Baur, Amber Alhadeff, and Maayan Levy. The study was supported in part by the National Institutes of Health (S10-OD021750, DP2AG067492, R01-DK-129691, , P01-DK119130 and R01-DK115578), the Pew Charitable Trust, the Edward Mallinckrodt, Jr. Foundation, the Agilent Early Career Professor Award, the Global Probiotics Council, the IDSA Foundation, the Thyssen Foundation, the Human Frontier Science Program, and Penn Medicine, including the Dean's Innovation Fund. RELATED TOPICS Health & Medicine Fitness Ulcers Gastrointestinal Problems Colitis Plants & Animals Mice Bacteria Veterinary Medicine Biology RELATED TERMS Anaerobic exercise Aerobic exercise Histamine Gastrointestinal tract Swimming Bacteria Physical exercise Gymnastics Story Source: Materials provided by University of Pennsylvania School of Medicine. Note: Content may be edited for style and length. Journal Reference: Dohnalová, L., Lundgren, P., Carty, J.R.E. et al. A microbiome-dependent gut–brain pathway regulates motivation for exercise. Nature, 2022 DOI: 10.1038/s41586-022-05525-z Cite This Page: MLA APA Chicago University of Pennsylvania School of Medicine. "Gut microbes can boost the motivation to exercise." ScienceDaily. ScienceDaily, 14 December 2022. .

Can We Put the Brakes on Parkinson’s Progression?

reposted from https://www.parkinson.org/blog/awareness/parkinsons-progress Can We Put the Brakes on Parkinson’s Progression? May 05, 2022 put breaks pd progression blog Researchers are lasered in on slowing and someday stopping Parkinson's disease (PD) in its tracks. Explore what they've discovered, see what the future might hold and learn how some of the strongest weapons in the fight against Parkinson's progression are practices you can put in place today. This article is based on Can We Put the Brakes on PD Progression, a Parkinson’s Foundation Expert Briefing webinar presented by Joash Lazarus, MD, Multiple Sclerosis Center of Atlanta. PD symptoms stem from a protein, called alpha-synuclein, that clumps and accumulates in certain areas of the brain. This process depletes dopamine, which is critical to many body processes, including smooth, coordinated movements. Though dopamine declines for everyone who lives with Parkinson's, each person experiences disease symptoms differently. Parkinson's symptoms can impact your life in numerous ways. Using a range of therapies and supports as needed can make all the difference. Personalized medicines, social support groups, mental health care and participation in clinical trials have all shown benefit to people with Parkinson's. But is there a way to slow Parkinson's progression? While scientists are evaluating everything from medications to mindfulness practice for clues, they've discovered some of the biggest benefits start at home. Healthy Eating and Regular Exercise: A Powerful Combo Making nutritious food the mainstay of your meals and enjoying regular exercise has countless proven benefits. Studies show targeted nutrition may slow Parkinson's advancement. Eating a whole-food, plant-based, Mediterranean-style diet — including fresh vegetables, fruit and berries, nuts, seeds, fish, olive and coconut oils and more — may be linked to slower PD progression. When you live with PD, exercise is also critical to optimal health. In fact, the Parkinson’s Outcomes Project shows at least 2.5 hours a week of physical activity can slow PD symptom progression. Research reveals regular exercise also shows neuroprotective effects in animal models with Parkinson's. Exercise benefits people of all ages. As people get older, their risk for falls increase. For people with PD, the chance of falls is two to three times higher. Up to half of these falls can result in major injury. Exercise is the only thing to notably minimize a person’s risk of falling. Regular physical activity can also boost balance, improve heart and lung function, increase memory, thinking and problem solving, minimize depression and more. Here's how to make exercise work for you: Maximize benefits by exercising moderately to vigorously 150 minutes a week. Plan a weekly routine that includes aerobic activity, strength training, balance and stretching exercises. Visit a physical therapist with Parkinson’s expertise for a functional evaluation and exercise recommendations. Reference this Parkinson’s Exercise Recommendations PDF in English or Spanish to help guide your physical activity plan. Specialized Parkinson's movement and speech therapies, such as the Lee Silverman Voice Treatment (LSVT) BIG and LOUD programs, have also shown potential to lessen symptoms and slow PD progression. Exploring Therapy Advances People with Parkinson's take a variety of medications to manage symptoms. PD researchers have spent decades working to discover therapies powerful enough to slow or stop Parkinson's. Some of these include: Rasagiline The 2009 ADAGIO study looked at whether rasagiline — a monoamine oxidase-B (MAO-B) inhibitor (these can minimize the enzyme MAO-B's breakdown of dopamine and ease movement symptoms) — could put the brakes on disease progression for people in early-stage Parkinson's. The results suggested the possibility that a 1 mg daily dose of rasagiline might hold disease-modifying potential, but a 2mg daily dose did not. Despite the study's uncertainties, it still showed ample evidence that rasagiline better controlled symptoms for people with PD, which is why it's used in concert with levodopa, currently the most powerful medication for Parkinson's and a treatment mainstay since its discovery in the 1960s. Levodopa Levodopa is a proven effective therapy throughout the Parkinson's journey. In the past, people often delayed starting levodopa therapy based on the myth that it would stop working after a few years. A 2019 study looked at whether starting levodopa earlier or later could change the course of Parkinson's. While research showed levodopa didn't slow PD, it proved starting the medication early on in Parkinson's is safe. Deep Brain Stimulation When people who live with PD begin to experience severe motor fluctuations, tremors and dyskinesia, involuntary muscle movements that can't be controlled by optimal medication doses, a surgically implanted deep brain stimulation (DBS) device can deliver electrical pulses to the brain, easing symptoms and boosting quality of life. Results of a 2020 study proved people with Parkinson's disease can also get long-term symptom relief with DBS. The research shows people who have DBS therapy early on — coupled with optimal medication — generally do better with dyskinesia control. Despite the profound benefits of DBS, it's not proven to delay disease progression. As researchers work to solve the Parkinson's puzzle, empower yourself by prioritizing your well-being. Wholesome food paired with regular exercise habits and comprehensive team-based treatment are the building blocks of a better life with PD. Additional Information The Parkinson’s Foundation Exercise Guidelines for People with Parkinson’s offers tips to stay in top shape. Learn more about PD therapies in Medications: A Treatment Guide to Parkinson’s Disease. Get moving with Fitness Fridays — Parkinson's Foundation PD-tailored at home workouts. Dig in to why what and how you eat matters with Mindfulness: Nutrition and Mindful Eating, part of our Mindfulness Mondays series.

Pineapple Pesticide Linked to Parkinson's Disease

reposted from https://www.nbcnews.com/health/health-news/pineapple-pesticide-linked-parkinsons-disease-n477346 Pineapple Pesticide Linked to Parkinson's Disease The pineapple pesticide made its way into milk in Hawaii and then into men's brains. A study is the latest to link pesticides to Parkinson's. Image: Pineapples lay in the middle of a large plantation Pineapples lay in the middle of a large plantation in January 2014.Kaveh Kazemi / Getty Images, file Link copied Dec. 9, 2015, 6:55 PM EST / Updated Dec. 9, 2015, 6:55 PM EST By Maggie Fox A pineapple pesticide that made its way into milk in Hawaii also made its way into men’s brains, and those men were more likely to develop Parkinson’s disease, a new study finds. It’s the latest in a very long series of studies linking various pesticides to Parkinson’s, which is caused by the loss of certain brain cells. And the study also seems to support a mystifying observation: smokers seem to be protected against Parkinson’s. For the study, Dr. Robert Abbott of the Shiga University of Medical Science in Otsu, Japan, and colleagues studied 449 Japanese-American men living in Hawaii who were taking part in a larger study of aging. They gave details of how much milk they drank as part of a larger survey, and they donated their brains for study after they died. “For people living with Parkinson's, understanding the impact of environmental factors is crucial." The men who drank more than 16 ounces of milk a day had the fewest brain cells in a part of the brain called the substantia nigra, which is damaged in Parkinson’s, they reported in the journal Neurology. The researchers also looked for the pesticide heptachlor, which was taken off the market for most uses in the U.S. in 1988. "Among those who drank the most milk, residues of heptachlor epoxide were found in nine of 10 brains as compared to 63.4 percent for those who consumed no milk," the researchers wrote. It’s known the milk in Hawaii was contaminated, probably from the feed given to the cattle. "The researchers could not test whether the milk the men drank was contaminated with pesticides (heptachlor, in this case), and no one knows how long or how widespread the contamination was before being detected," the Parkinson’s Disease Foundation said in a statement on its website. Recommended OUT NEWS Trans physician uses life savings to keep clinic open after insurers deny reimbursements HEALTH NEWS As weight loss drugs soar in popularity, many who could benefit can't get them "The potential link between drinking milk, pesticides and development of Parkinson’s disease needs further investigation," the foundation said. The men who smoked and who also drank milk showed none of the brain cell loss. "This study is unique because it brings together two critical but different pieces of information — environmental exposure and physical changes in the brain — to understand potential contributors of Parkinson’s disease," James Beck, vice president of scientific affairs at the Parkinson's Disease Foundation, said in a statement. “The potential link between drinking milk, pesticides and development of Parkinson’s disease needs further investigation.” "For people living with Parkinson's, understanding the impact of environmental factors is crucial as nearly 85 percent have no idea why they developed Parkinson’s. There is no clear genetic link," Beck said. The Parkinson's Disease Foundation estimates that 1 million Americans have the condition, marked by tremor, rigid muscles and problems with movement. There is no cure, although early treatment can delay the worst symptoms. "For scientists, the opportunity to study brains generously donated by the participants of this study was crucial to establishing a potential link between different environmental exposures and Parkinson’s, and will be crucial to solving the disease overall," Beck said. Maggie Fox Maggie Fox is a senior writer for NBC News and TODAY, covering health policy, science, medical treatments and disease.

Mitochondrial Metabolism Dictates Neurons’ Growth Rate

reposted from Mitochondrial Metabolism Dictates Neurons’ Growth Rate Altering the rate of respiration in mitochondria changes how fast neurons grow, making mouse neurons grow more like human ones and vice versa, a study finds. a human neuron illuminated in bright green on a black background. A black and white headshot of Katherine Irving Katherine Irving Jan 30, 2023 | 4 min read PDF VERSION ABOVE: A human cortical neuron RYOHEI IWATA Human brains grow extraordinarily slowly—a trait many neuroscientists speculate is related to our distinctive intellect. But how and why a human neuron takes years to grow when a mouse neuron grows for mere weeks has remained unclear. Now, scientists have uncovered one piece of the puzzle: Neuron growth is mediated by its mitochondria’s metabolism, according to a January 26 study in Science. The finding could not only help answer fundamental questions about brain development, the study authors say it could widen treatment options for developmental disorders. “This is the most exciting study I’ve read in a while,” says Suzana Herculano-Houzel, a biologist and neuroscientist at Vanderbilt University who wasn’t involved in the research. “It opens a path for finding answers to, what is to me, one of the biggest questions we have: What makes different brains different?” For senior study author and developmental biologist Pierre Vanderhaeghen, the underlying cause of human neurons’ prolonged growth had long lay tantalizingly out of reach. Nearly a decade ago, he and colleagues at the Free University of Brussels in Belgium put human cortical neurons inside mouse brains, expecting them to grow faster. But to their surprise, the human neurons still grew slowly when transplanted. This suggested to Vanderhaeghen, who also works at the Flanders Institute for Biotechnology and the Catholic University of Leuven, that the cause of a neuron’s glacial growth was intrinsic to the neuron itself and not the consequence of signals from the surrounding brain, he explains. Moreover, he and his colleagues at the time noted that every single aspect of the neuron, from its dendrites to its synapses to its axon, grows in synchrony, indicating that the growth is regulated by a ubiquitous, basal component of the cell. Other research had posited that mitochondria may somehow play important roles in the development of cells. So he and his team set out to investigate whether mitochondria are involved in regulating neuron growth. A purple human neuron with white mitochondria dotting the surface A human neuron with mitochondria stained in white RYOHEI IWATA First, though, they needed to ensure they could accurately pinpoint the age of any given neuron. Knowing a neuron’s age is vital for gauging its growth over time, but getting an exact birthdate for each neuron had been next to impossible, Vanderhaeghen explains, as neurons don’t develop at the same rate as one another, even when their original stem cells are created at the same time. However, stem cells can only become neurons after promoter NeuroD1 is activated. So Vanderhaeghen and colleagues came up with a genetic tool that uses an engineered recombinase enzyme called CreER that identifies when NeuroD1 is turned on and immediately tags the neuron—essentially flagging its “birth.” With the ability to date the neurons, Vanderhaeghen and his team could start testing the effect mitochondria have on neuron growth rates. Initially, Vanderhaeghen says, the team examined mitochondrial morphology and genetics. But on a whim, they also decided to look at the organelles’ respiration rates—basically, how much oxygen they consume, which is also a measure of how much cellular fuel they produce. They used oxygraphy to monitor the oxygen intake of mouse neurons for the first 20 days after their birth—and were stunned to find that after two weeks, the oxygen consumption rate of neurons had grown to nearly ten times that of human neurons. From there, Vanderhaeghen says everything fell into place. The team knew they could manipulate mitochondrial respiration pharmacologically, so they sped up metabolism in human cortical neurons in vitro. Vanderhaeghen recalls a moment in the lab looking at the neurons; at only a few weeks old, the accelerated cortical neurons were considerably more mature than a normal human neuron. “To us, this was a big eureka moment,” he says. “There we thought, ‘this is it.’” The scientists tested the same principle in vivo, speeding up the mitochondrial metabolism of human neurons and implanting them into mice, as well as slowing down the mitochondrial metabolism of mouse neurons both in culture and inside the mice’s brains. The results from both in and out of the brain aligned: Human neurons with increased metabolic rates grew faster than normal, and mouse neurons with decreased mitochondrial metabolic rates displayed slower growth. Many scientists theorize that the human brain’s slow growth is part of what allows for our unique mental capacities. Knowing that a metabolism regulator can slow or speed up that growth will allow for further studies into what makes us human, Vanderhaeghen posits. He adds that targeting mitochondrial metabolism could one day be considered in the treatment of some developmental disorders, which can arise from brain development that is either too fast or too slow. However, he emphasizes that this study is only the beginning. “I would be very naive to think that mitochondria are the [only] solution” to resolving issues related to developmental timing, he says. “Mitochondria are just one mechanism, and there are probably going to be many others.” Nonetheless, Herculano-Houzel is excited to see where this research will go. “That is the definition of good science: You answer one question, and that brings up ten new questions you didn’t know you had,” she says. “What happens if you play with energy transfer in a developing brain? Do you directly affect the size of the brain? Do you affect how many neurons are generated? These are all fundamental questions, and they can all be asked now.” Keywords: brain developmentbrain plasticitycell biologycortical neurondevelopmental biologydevelopmental delaygrowthhuman cognitionmetabolismmicrobiologymitochondriamouse brainneural developmentneuronal plasticityneuronsNewsNews Brief